AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Lilly's Direct-to-Consumer Strategy
This chapter explores Lilly's strategic shift to a direct-to-consumer model for their medications in response to compounded drugs' popularity. It addresses the implications for consumer access, data collection concerns, and recent changes in drug pricing and couponing programs.